| VFSAX | VFSNX | VFSAX / VFSNX | |
| Total Expense Ratio | 0.16 | 0.08 | 200% |
| Annual Report Gross Expense Ratio | 0.16 | 0.08 | 200% |
| Fund Existence | 7 years | 17 years | - |
| Gain YTD | 9.718 | 9.759 | 100% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 3000 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 14.3B | 14.3B | 100% |
| Annual Yield % from dividends | 2.95 | 2.99 | 98% |
| Returns for 1 year | 21.85 | 21.87 | 100% |
| Returns for 3 years | 45.47 | 45.57 | 100% |
| Returns for 5 years | 21.19 | 21.30 | 99% |
| Returns for 10 years | N/A | 89.95 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| NQQQX | 55.06 | 1.64 | +3.07% |
| Shelton Nasdaq-100 Index Institutional | |||
| CTSOX | 64.46 | 1.12 | +1.77% |
| Calamos Timpani Small Cap Growth R6 | |||
| SVALX | 7.10 | N/A | N/A |
| Federated Hermes Strategic Value Div R6 | |||
| GMSRX | 14.80 | N/A | N/A |
| Nationwide Small Cap Index R | |||
| LYFCX | 16.07 | N/A | N/A |
| AlphaCentric Life Sciences & Hlthcare C | |||